NBRV Annual Net Income
-$57.19 M
-$7.74 M-15.64%
31 December 2022
Summary:
As of February 1, 2025, NBRV annual net profit is -$57.19 million, with the most recent change of -$7.74 million (-15.64%) on December 31, 2022. During the last 3 years, it has risen by +$25.58 million (+30.91%).NBRV Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBRV Quarterly Net Income
-$8.70 M
+$14.08 M+61.81%
31 March 2023
Summary:
As of February 1, 2025, NBRV quarterly net profit is -$8.70 million, with the most recent change of +$14.08 million (+61.81%) on March 31, 2023. Over the past year, it has increased by +$3.12 million (+26.39%).NBRV Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBRV TTM Net Income
-$54.07 M
+$3.12 M+5.45%
31 March 2023
Summary:
As of February 1, 2025, NBRV TTM net profit is -$54.07 million, with the most recent change of +$3.12 million (+5.45%) on March 31, 2023. Over the past year, it has dropped by -$6.78 million (-14.33%).NBRV TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBRV Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.6% | +26.4% | -14.3% |
| 3 y3 years | +30.9% | +62.6% | +37.0% |
| 5 y5 years | +23.1% | +34.8% | +34.7% |
NBRV Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -469.4% | +298.6% | +1473.1% |
Nabriva Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$8.70 M(-61.8%) | -$54.07 M(-5.5%) |
| Dec 2022 | -$57.19 M(+15.6%) | -$22.78 M(+97.8%) | -$57.19 M(+20.5%) |
| Sept 2022 | - | -$11.51 M(+4.0%) | -$47.47 M(+1.8%) |
| June 2022 | - | -$11.07 M(-6.3%) | -$46.61 M(-1.4%) |
| Mar 2022 | - | -$11.82 M(-9.5%) | -$47.29 M(-4.4%) |
| Dec 2021 | -$49.45 M(-28.8%) | -$13.06 M(+22.6%) | -$49.45 M(-8.8%) |
| Sept 2021 | - | -$10.65 M(-9.4%) | -$54.22 M(-4.1%) |
| June 2021 | - | -$11.75 M(-15.9%) | -$56.52 M(-6.1%) |
| Mar 2021 | - | -$13.98 M(-21.6%) | -$60.21 M(-13.4%) |
| Dec 2020 | -$69.48 M(-16.0%) | -$17.83 M(+37.7%) | -$69.48 M(-7.0%) |
| Sept 2020 | - | -$12.95 M(-16.1%) | -$74.70 M(-6.1%) |
| June 2020 | - | -$15.44 M(-33.6%) | -$79.54 M(-7.3%) |
| Mar 2020 | - | -$23.26 M(+0.9%) | -$85.81 M(+3.7%) |
| Dec 2019 | -$82.76 M(-27.9%) | -$23.05 M(+29.5%) | -$82.76 M(-8.6%) |
| Sept 2019 | - | -$17.80 M(-18.0%) | -$90.54 M(-27.9%) |
| June 2019 | - | -$21.71 M(+7.4%) | -$125.57 M(+3.2%) |
| Mar 2019 | - | -$20.22 M(-34.4%) | -$121.66 M(+6.0%) |
| Dec 2018 | -$114.78 M | -$30.82 M(-41.6%) | -$114.78 M(+8.1%) |
| Sept 2018 | - | -$52.83 M(+197.0%) | -$106.22 M(+40.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$17.79 M(+33.3%) | -$75.66 M(+4.4%) |
| Mar 2018 | - | -$13.34 M(-40.1%) | -$72.47 M(-2.5%) |
| Dec 2017 | -$74.36 M(+35.5%) | -$22.26 M(-0.0%) | -$74.36 M(+10.5%) |
| Sept 2017 | - | -$22.27 M(+52.5%) | -$67.28 M(+14.0%) |
| June 2017 | - | -$14.60 M(-4.1%) | -$59.01 M(+4.4%) |
| Mar 2017 | - | -$15.22 M(+0.2%) | -$56.51 M(+3.0%) |
| Dec 2016 | -$54.89 M(+16.9%) | -$15.19 M(+8.5%) | -$54.89 M(-12.6%) |
| Sept 2016 | - | -$14.00 M(+15.7%) | -$62.83 M(+10.1%) |
| June 2016 | - | -$12.10 M(-11.0%) | -$57.04 M(+12.2%) |
| Mar 2016 | - | -$13.60 M(-41.2%) | -$50.83 M(+8.2%) |
| Dec 2015 | -$46.96 M(+230.2%) | -$23.12 M(+181.5%) | -$46.96 M(+68.1%) |
| Sept 2015 | - | -$8.21 M(+39.3%) | -$27.94 M(+15.3%) |
| June 2015 | - | -$5.90 M(-39.4%) | -$24.23 M(+18.1%) |
| Mar 2015 | - | -$9.73 M(+137.5%) | -$20.52 M(+44.3%) |
| Dec 2014 | -$14.22 M(-191.9%) | -$4.10 M(-9.0%) | -$14.22 M(+40.5%) |
| Sept 2014 | - | -$4.51 M(+106.4%) | -$10.12 M(+80.2%) |
| June 2014 | - | -$2.18 M(-36.5%) | -$5.62 M(+63.5%) |
| Mar 2014 | - | -$3.44 M | -$3.44 M |
| Dec 2013 | $15.48 M | - | - |
FAQ
- What is Nabriva Therapeutics annual net profit?
- What is the all time high annual net income for Nabriva Therapeutics?
- What is Nabriva Therapeutics annual net income year-on-year change?
- What is Nabriva Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Nabriva Therapeutics?
- What is Nabriva Therapeutics quarterly net income year-on-year change?
- What is Nabriva Therapeutics TTM net profit?
- What is the all time high TTM net income for Nabriva Therapeutics?
- What is Nabriva Therapeutics TTM net income year-on-year change?
What is Nabriva Therapeutics annual net profit?
The current annual net income of NBRV is -$57.19 M
What is the all time high annual net income for Nabriva Therapeutics?
Nabriva Therapeutics all-time high annual net profit is $15.48 M
What is Nabriva Therapeutics annual net income year-on-year change?
Over the past year, NBRV annual net profit has changed by -$7.74 M (-15.64%)
What is Nabriva Therapeutics quarterly net profit?
The current quarterly net income of NBRV is -$8.70 M
What is the all time high quarterly net income for Nabriva Therapeutics?
Nabriva Therapeutics all-time high quarterly net profit is -$2.18 M
What is Nabriva Therapeutics quarterly net income year-on-year change?
Over the past year, NBRV quarterly net profit has changed by +$3.12 M (+26.39%)
What is Nabriva Therapeutics TTM net profit?
The current TTM net income of NBRV is -$54.07 M
What is the all time high TTM net income for Nabriva Therapeutics?
Nabriva Therapeutics all-time high TTM net profit is -$3.44 M
What is Nabriva Therapeutics TTM net income year-on-year change?
Over the past year, NBRV TTM net profit has changed by -$6.78 M (-14.33%)